| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,572 |
5,177 |
$51K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,186 |
1,157 |
$33K |
| 92587 |
|
1,954 |
1,888 |
$30K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,508 |
3,488 |
$27K |
| 96127 |
|
2,390 |
2,316 |
$22K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
296 |
292 |
$21K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,496 |
1,445 |
$19K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,164 |
1,111 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
312 |
308 |
$12K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,049 |
2,368 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
194 |
191 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,053 |
1,030 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
586 |
586 |
$4K |
| 83655 |
|
300 |
299 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
174 |
174 |
$3K |
| 87634 |
|
47 |
46 |
$3K |
| 90834 |
Psychotherapy, 45 minutes with patient |
13 |
12 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
780 |
776 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
113 |
106 |
$2K |
| 99051 |
|
179 |
172 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
51 |
51 |
$1K |
| 92558 |
|
71 |
70 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
420 |
419 |
$1K |
| 87070 |
|
99 |
95 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
53 |
52 |
$1K |
| 99177 |
|
298 |
298 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
39 |
39 |
$1K |
| 90661 |
|
334 |
333 |
$611.58 |
| 99173 |
|
532 |
528 |
$478.65 |
| 87400 |
|
44 |
28 |
$477.56 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
42 |
$447.25 |
| 99188 |
|
17 |
17 |
$416.00 |
| 81002 |
|
120 |
118 |
$360.73 |
| 81000 |
|
32 |
32 |
$201.84 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
205 |
205 |
$178.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
274 |
274 |
$177.91 |
| 85018 |
|
86 |
85 |
$155.64 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
16 |
16 |
$93.08 |
| 36416 |
|
55 |
54 |
$0.00 |
| 90686 |
|
35 |
35 |
$0.00 |
| 90677 |
|
12 |
12 |
$0.00 |
| 90648 |
|
24 |
24 |
$0.00 |
| 99072 |
|
759 |
667 |
$0.00 |
| 90670 |
|
12 |
12 |
$0.00 |